Results 261 to 270 of about 2,184,778 (369)

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Pharmacological evidences for the blood pressure lowering and cardiovascular inhibitory actions of the essential oil of <i>Thymus serrulatus</i> hochst. Ex benth. [PDF]

Front Pharmacol
Rehman NU, Ansari MN, Aldossari AA, Alhatlan TA, Palla AH, Karim A, Noman M.   +6 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Complete Congenital Absence of Left Pericardium: A Case Report. [PDF]

Cureus
Gupta S, Kumar D.
europepmc   +1 more source

Cracking the code of complex atrial tachyarrhythmias after heart transplantation: Can ultra-high-density mapping provide the key? [PDF]

HeartRhythm Case Rep
Teunissen C, Kassenberg W, Oerlemans MIFJ, Mokhles MM, Loh P, Hendriks AA.   +5 more
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Surgical management of a patient with mirror-image dextrocardia with situs inversus, atrial septal defect, moderate tricuspid regurgitation, and moderate to severe pulmonary hypertension: a case report. [PDF]

J Cardiothorac Surg
Chen P, Gong Q, Lu B, Zheng G, Ke X, Chen C.   +5 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Analysis of atrioventricular function and myocardial strain in hypertensive heart disease: a CMR-based study. [PDF]

Sci Rep
Niu J, Zhu J, Wang Y, Chen J, Li H, Qu Y, Li X, Sheng W, Wang S.   +8 more
europepmc   +1 more source

Alterations in Heart Rate and Atria to Ventricular Conductivity in Third Trimester Pregnancy: A Comparative Study

, 2015
Sonam Chaudhary, C G Saha, Dipali Sarkar
openalex   +2 more sources